INHIBIKASE THERAPEUTIC

2,3600

26-ноября-24 16:45:00

15 мин. задержка

Акции

+0,0200

+0,85%

Сегодняшний диапазон

2,2596 - 2,4800

ISIN

N/A

Источник

NASDAQ

Inhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001Pro

04 дек 2023 08:35:00 Источник Nasdaq GlobeNewswire
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity

14 ноя 2023 16:30:06 Источник Nasdaq GlobeNewswire
Correcting & Replacing -- Inhibikase Therapeutics to Report Third Quarter Financial Results on November 14, 2023

07 ноя 2023 09:28:32 Источник Nasdaq GlobeNewswire
Inhibikase Therapeutics to Report Second Quarter Financial Results on November 14, 2023

07 ноя 2023 08:00:01 Источник Nasdaq GlobeNewswire
Inhibikase Therapeutics Highlights Unblinded Functional Analysis from the 201 Trial of Risvodetinib in Untreated Parkinson’s Disease and Provides Update on Ongoing Enrollment

16 окт 2023 07:00:27 Источник Nasdaq GlobeNewswire
Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy

04 окт 2023 08:30:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.